Contributors |
|
xix | |
Preface: Concluding the Series |
|
xxiii | |
Glossary |
|
xxix | |
|
|
|
1 Structural and Functional Properties of Glutamate Dehydrogenases |
|
|
1 | (14) |
|
|
|
|
1 | (1) |
|
|
1 | (1) |
|
|
2 | (2) |
|
1.3.1 Substrate and cofactor binding |
|
|
2 | (1) |
|
1.3.2 Tertiary and quaternary structure |
|
|
3 | (1) |
|
1.4 Enzyme Mechanism and Kinetics |
|
|
4 | (3) |
|
|
7 | (1) |
|
|
8 | (2) |
|
|
10 | (5) |
|
|
11 | (4) |
|
2 Glutamate Decarboxylase in Bacteria |
|
|
15 | (14) |
|
|
|
|
|
15 | (1) |
|
|
15 | (4) |
|
2.2.1 Centrality of L-glutamate in bacterial metabolism |
|
|
15 | (2) |
|
2.2.2 Importance of L-glutamate in the acid stress response: the GDAR system |
|
|
17 | (2) |
|
2.3 Glutamate Decarboxylase (Gad) in Bacteria |
|
|
19 | (4) |
|
2.3.1 Escherichia coli Gad |
|
|
19 | (1) |
|
2.3.1.1 Structural studies |
|
|
19 | (2) |
|
2.3.1.2 Spectroscopic properties |
|
|
21 | (1) |
|
|
21 | (1) |
|
2.3.2 Other bacterial Gads |
|
|
22 | (1) |
|
2.3.2.1 GadB from Clostridium perfringens |
|
|
22 | (1) |
|
2.3.2.2 GadB from Brucella microti |
|
|
22 | (1) |
|
2.3.2.3 GadB from lactic acid bacteria |
|
|
22 | (1) |
|
2.4 Use of Gad for γ-Aminobutyrate (GABA) Production: a Beneficial Molecule for our Society |
|
|
23 | (1) |
|
2.4.1 GABA in health and disease |
|
|
23 | (1) |
|
2.4.2 GABA as an alternative promising molecule for sustainable resources |
|
|
24 | (1) |
|
|
24 | (5) |
|
|
25 | (4) |
|
3 The Yeast γ-Aminobutyrate (GABA) Shunt |
|
|
29 | (20) |
|
|
|
29 | (1) |
|
|
29 | (2) |
|
3.3 Metabolism of GABA -- the GABA Shunt |
|
|
31 | (3) |
|
3.3.1 Glutamate decarboxylase |
|
|
31 | (1) |
|
3.3.2 GABA aminotransferase |
|
|
32 | (1) |
|
3.3.3 Succinate semialdehyde dehydrogenase |
|
|
33 | (1) |
|
3.4 Regulation of the Yeast GABA Shunt |
|
|
34 | (5) |
|
3.5 The Role of the Yeast GABA Shunt in Environmental Stress Responses |
|
|
39 | (2) |
|
|
41 | (8) |
|
|
42 | (1) |
|
|
42 | (7) |
|
PART II LYSINE, ARGININE AND HYDROXYPROLINE |
|
|
|
4 Lysine Biosynthesis in Microorganisms |
|
|
49 | (21) |
|
|
|
|
|
|
49 | (1) |
|
|
49 | (1) |
|
4.2.1 The amino acid lysine |
|
|
49 | (1) |
|
4.2.2 The aspartate-derived amino acids |
|
|
50 | (1) |
|
4.3 Lysine Biosynthesis in Microorganisms |
|
|
50 | (1) |
|
4.3.1 The α-aminoadipate (AAA) pathway |
|
|
51 | (1) |
|
4.4 Lysine Biosynthesis in Bacteria: the Diaminopimelate (DAP) Pathways |
|
|
51 | (9) |
|
4.4.1 The DAP acyl pathways |
|
|
52 | (6) |
|
4.4.2 The meso-diaminopimelate (meso-DAP) dehydrogenase (Ddh) pathway |
|
|
58 | (1) |
|
4.4.3 L,L-Diaminopimelate aminotransferase (DapL) pathway: a novel variant of the DAP pathways |
|
|
58 | (2) |
|
4.5 Insights on Bridging the Metabolic Gap Between Tetrahydrodipicolinate (THDP) and L,L-DAP in Plants and Bacteria That Do Not Contain Orthologues of the DAP Pathway Enzymes DapD, DapC and DapE |
|
|
60 | (1) |
|
4.6 The Discovery of the L,L-Diaminopimelate Aminotransferase (DapL) Variant Pathway |
|
|
60 | (2) |
|
4.7 The Link Between Lysine and Bacterial Peptidoglycan (PG) Biosynthesis |
|
|
62 | (1) |
|
|
63 | (7) |
|
|
64 | (1) |
|
|
64 | (6) |
|
5 Arginine Deiminase in Microorganisms |
|
|
70 | (11) |
|
|
|
|
70 | (1) |
|
|
70 | (1) |
|
|
71 | (4) |
|
5.3.1 Overview of the pathway and its enzymes |
|
|
71 | (1) |
|
|
71 | (2) |
|
5.3.3 Regulation of the pathway |
|
|
73 | (2) |
|
5.4 Ecological Situation and Examples |
|
|
75 | (2) |
|
5.4.1 Role in ecological adaptation |
|
|
75 | (1) |
|
5.4.2 Examples from (clinical) non-food ecosystems |
|
|
75 | (1) |
|
5.4.3 Examples from food ecosystems |
|
|
76 | (1) |
|
|
77 | (4) |
|
|
77 | (1) |
|
|
77 | (4) |
|
6 Arginase and Microbial Pathogenesis in the Lungs |
|
|
81 | (10) |
|
|
|
|
|
|
|
81 | (1) |
|
|
81 | (1) |
|
6.3 Importance of Exotoxins From G+ Bacteria in Permeability Oedema |
|
|
82 | (1) |
|
6.4 Importance of L-Arginine in Pneumococcal Physiological Fitness |
|
|
83 | (1) |
|
6.5 Role of L-Arginine in Alveolar Macrophage Polarization During Pneumococcal Pneumonia |
|
|
83 | (2) |
|
6.6 Opposing Actions of Arginase and Endothelial Nitric Oxide Synthase (eNOS) in Capillary Barrier Regulation |
|
|
85 | (2) |
|
|
87 | (4) |
|
|
87 | (1) |
|
|
87 | (4) |
|
7 Arginine and Methionine as Precursors of Polyamines in Trypanosomatids |
|
|
91 | (25) |
|
|
|
|
|
91 | (1) |
|
7.2 Trypanosomatid-borne Diseases |
|
|
91 | (2) |
|
7.3 L-Methionine Metabolism |
|
|
93 | (4) |
|
7.3.1 L-Methionine and S-adenosyl-L-methionine (AdoMet) uptake |
|
|
93 | (2) |
|
|
95 | (1) |
|
7.3.3 The transsulfuration pathway |
|
|
95 | (1) |
|
7.3.4 L-Methionine regeneration: the folate cycle |
|
|
96 | (1) |
|
7.3.5 The 5'-methylthioadenosine salvage pathway |
|
|
96 | (1) |
|
7.4 L-Arginine Metabolism |
|
|
97 | (3) |
|
|
97 | (2) |
|
|
99 | (1) |
|
7.4.3 Phosphagen production |
|
|
100 | (1) |
|
|
100 | (4) |
|
7.5.1 Polyamine biosynthesis in mammals: the canonical pathway |
|
|
100 | (1) |
|
7.5.2 Polyamine metabolism in trypanosomatids |
|
|
101 | (3) |
|
7.6 Role of L-Arginine in Host-Parasite Interactions |
|
|
104 | (2) |
|
7.7 Polyamines as Potential Targets for Drug Development |
|
|
106 | (2) |
|
|
108 | (8) |
|
|
109 | (1) |
|
|
109 | (7) |
|
8 Ornithine and Lysine Decarboxylation in Bacteria |
|
|
116 | (12) |
|
|
|
116 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
8.4 The Ornithine Decarboxylase (ODC) and Lysine Decarboxylase (LDC) Systems |
|
|
118 | (2) |
|
8.4.1 Putrescine and cadaverine production systems |
|
|
118 | (1) |
|
|
118 | (1) |
|
8.4.2.1 Genetic organization of the odc operon |
|
|
118 | (1) |
|
8.4.2.2 L-Ornithine decarboxylase |
|
|
119 | (1) |
|
8.4.2.3 The ornithine/putrescine exchanger |
|
|
119 | (1) |
|
|
119 | (1) |
|
8.4.3.1 The cad operon of enterobacteria |
|
|
119 | (1) |
|
8.4.3.2 The LDC locus of the LAB strain Lactobacillus saerimneri 30a |
|
|
119 | (1) |
|
8.4.3.3 L-Lysine decarboxylase |
|
|
120 | (1) |
|
8.4.3.4 The lysine/cadaverine exchanger |
|
|
120 | (1) |
|
8.5 ODC-and LDC-Positive Bacteria |
|
|
120 | (2) |
|
8.5.1 Origin and diversity of bacteria |
|
|
120 | (1) |
|
|
121 | (1) |
|
8.5.3 Lactic acid bacteria |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
8.6 Physiological Role of ODC and LDC |
|
|
122 | (1) |
|
8.6.1 Acid resistance and energy production |
|
|
122 | (1) |
|
8.6.2 Cad Genes and the virulence of pathogenic strains of Escherichia coli |
|
|
122 | (1) |
|
8.7 Food Safety Implications |
|
|
123 | (1) |
|
8.7.1 Origin of biogenic amines in food |
|
|
123 | (1) |
|
8.7.2 Toxicological effects of food-borne biogenic amines |
|
|
123 | (1) |
|
8.7.3 Control of biogenic amine formation in food |
|
|
124 | (1) |
|
|
124 | (4) |
|
|
124 | (4) |
|
9 The Role of Nitric Oxide Signalling in Yeast Stress Response and Cell Death |
|
|
128 | (14) |
|
|
|
|
|
|
128 | (1) |
|
|
128 | (1) |
|
9.3 Nitric Oxide Biosynthesis in Yeast |
|
|
129 | (2) |
|
9.4 Nitric Oxide Signalling |
|
|
131 | (5) |
|
9.4.1 The nitrosative stress response in yeast |
|
|
132 | (2) |
|
9.4.2 Nitric oxide signalling in the yeast stress response |
|
|
134 | (2) |
|
9.5 Nitric Oxide Signalling in Yeast Cell Death and Ageing |
|
|
136 | (2) |
|
|
138 | (4) |
|
|
138 | (4) |
|
10 Hydroxyproline Metabolism in Microorganisms |
|
|
142 | (11) |
|
|
|
142 | (1) |
|
10.3 Metabolic Pathway of trans-4-Hydroxy-L-Proline (T4LHyp) in Mammals |
|
|
143 | (1) |
|
10.4 Metabolic Pathway of T4LHyp in Bacteria |
|
|
143 | (4) |
|
10.4.1 Hydroxyproline 2-epimerase |
|
|
144 | (1) |
|
10.4.2 D-Hydroxyproline dehydrogenase |
|
|
144 | (1) |
|
10.4.3 Δ1-Pyrroline-4-hydroxy-2-carboxylate (Pyr4H2C) deaminase |
|
|
145 | (2) |
|
10.4.4 α-Ketoglutaric semialdehyde dehydrogenase |
|
|
147 | (1) |
|
10.5 Metabolic Pathway of trans-3-Hydroxy-L-Proline (T3LHyp) |
|
|
147 | (2) |
|
10.5.1 T3LHyp dehydratase |
|
|
147 | (1) |
|
10.5.2 Δ1-Pyrroline-2-carboxylate (Pyr2C) reductase |
|
|
147 | (2) |
|
10.6 Metabolic Pathway of cis-3-Hydroxy-L-Proline (C3LHyp) |
|
|
149 | (1) |
|
10.6.1 C3LHyp dehydratase |
|
|
149 | (1) |
|
|
149 | (1) |
|
10.7 T4LHyp Betaine Metabolism |
|
|
149 | (1) |
|
10.8 Hydroxyproline Metabolism in Archaea |
|
|
150 | (1) |
|
10.9 Hydroxyproline Metabolism in Fungi |
|
|
150 | (1) |
|
10.10 Enzymatic Detection of Hydroxyproline |
|
|
150 | (1) |
|
|
151 | (2) |
|
|
151 | (2) |
|
PART III SERINE AND THREONINE |
|
|
|
11 Cellular Responses to Serine in Yeast |
|
|
153 | (17) |
|
|
|
|
153 | (1) |
|
|
153 | (3) |
|
11.2.1 Metabolic roles of L-serine |
|
|
153 | (2) |
|
11.2.2 Role of L-serine in the cell walls of yeast and other fungi |
|
|
155 | (1) |
|
11.2.3 Role of L-serine in the heat-shock response |
|
|
155 | (1) |
|
11.3 Uptake and Synthesis of L-Serine and Glycine and the Central Role of One-Carbon Metabolism |
|
|
156 | (3) |
|
11.3.1 Uptake of L-serine and glycine |
|
|
156 | (1) |
|
11.3.2 Synthesis of L-serine and glycine |
|
|
156 | (1) |
|
11.3.3 Central role of one-carbon metabolism in synthesis and interconversion of glycine and L-serine |
|
|
157 | (2) |
|
11.4 Cellular Responses to Excess L-Serine and Glycine |
|
|
159 | (3) |
|
11.5 Regulation of L-Serine and Glycine Metabolism |
|
|
162 | (3) |
|
11.5.1 Control of L-serine and glycine uptake |
|
|
162 | (1) |
|
11.5.2 Regulation of L-serine and glycine metabolism |
|
|
163 | (1) |
|
11.5.3 Differences in L-serine metabolic networks and regulation between aerobic and anaerobic growth |
|
|
164 | (1) |
|
|
165 | (5) |
|
|
165 | (1) |
|
|
165 | (5) |
|
12 Threonine Degradation in Hyperthermophilic Organisms |
|
|
170 | (9) |
|
|
|
|
|
170 | (1) |
|
|
170 | (1) |
|
12.3 Threonine Degradation Pathways |
|
|
171 | (2) |
|
12.4 Threonine Degradation in Hyperthermophiles |
|
|
173 | (3) |
|
|
176 | (3) |
|
|
176 | (3) |
|
PART IV SULFUR AMINO ACIDS |
|
|
|
13 Methionine Synthesis in Microbes |
|
|
179 | (19) |
|
|
|
|
179 | (1) |
|
|
179 | (2) |
|
13.3 Bacterial Methionine Biosynthesis |
|
|
181 | (2) |
|
13.3.1 Acylation: activation of homoserine |
|
|
181 | (1) |
|
13.3.2 Sulfuration: from homoserine to homocysteine |
|
|
181 | (1) |
|
13.3.2.1 Direct sulfuration |
|
|
182 | (1) |
|
13.3.2.2 One-step synthesis |
|
|
182 | (1) |
|
13.3.2.3 Transsulfuration |
|
|
182 | (1) |
|
13.3.3 Methylation: from homocysteine to methionine |
|
|
183 | (1) |
|
13.4 Regulation of Methionine Biosynthesis |
|
|
183 | (10) |
|
13.4.1 Mechanisms of control of methionine biosynthesis |
|
|
183 | (1) |
|
13.4.1.1 Protein-mediated transcription control (transcription factors) |
|
|
183 | (2) |
|
13.4.1.2 RNA-mediated transcription control (riboswitches) |
|
|
185 | (4) |
|
13.4.2 Methionine metabolism and its control in selected bacterial species |
|
|
189 | (1) |
|
13.4.2.1 Escherichia coli |
|
|
189 | (1) |
|
13.4.2.2 Corynebacterium glutamicum |
|
|
190 | (1) |
|
13.4.2.3 Bacillus subtilis |
|
|
190 | (2) |
|
13.4.2.4 Staphylococcus aureus |
|
|
192 | (1) |
|
13.5 Methionine Biosynthesis as a Target for Novel Antibacterial Strategies |
|
|
193 | (1) |
|
13.5.1 Methionine biosynthesis enzyme and regulator protein inhibition |
|
|
193 | (1) |
|
13.5.2 Riboswitches as drug targets |
|
|
193 | (1) |
|
|
194 | (4) |
|
|
194 | (4) |
|
14 Regulation of Sulfur Amino Acid Metabolism in Fungi |
|
|
198 | (13) |
|
|
|
198 | (1) |
|
|
198 | (1) |
|
14.3 Useful Sources of Sulfur |
|
|
199 | (1) |
|
14.4 Response to Sulfur Limitation Related to Acquisition |
|
|
200 | (2) |
|
14.4.1 Direct acquisition of cysteine and methionine |
|
|
201 | (1) |
|
14.5 Adjustments to Cellular Protein Sulfur Composition |
|
|
202 | (1) |
|
14.6 Sulfur Assimilation and the Synthesis of Cysteine and Methionine |
|
|
202 | (1) |
|
14.7 Components of the Sulfur Regulatory System |
|
|
203 | (3) |
|
14.7.1 The CYS3 regulator |
|
|
203 | (1) |
|
14.7.2 Sulfur controller regulators |
|
|
204 | (1) |
|
14.7.3 The sulfur signal and sensor |
|
|
205 | (1) |
|
14.8 Operation of the Sulfur Regulatory System |
|
|
206 | (1) |
|
14.9 Regulatory Comparison with Other Fungi |
|
|
206 | (1) |
|
|
207 | (4) |
|
|
208 | (3) |
|
15 Insights on O-Acetylserine Sulfhydrylase Structure, Function and Biopharmaceutical Applications |
|
|
211 | (12) |
|
|
|
|
211 | (1) |
|
|
211 | (2) |
|
|
213 | (1) |
|
15.4 Function and Regulation |
|
|
214 | (2) |
|
15.5 Moonlighting Activities |
|
|
216 | (1) |
|
15.6 Biopharmaceutical Applications |
|
|
217 | (1) |
|
|
218 | (5) |
|
|
218 | (5) |
|
PART V BRANCHED-CHAIN AMINO ACIDS |
|
|
|
16 Metabolic Engineering of Corynebacterium glutamicum for L-Valine Production |
|
|
223 | (11) |
|
|
|
|
223 | (1) |
|
|
223 | (1) |
|
16.3 Biosynthetic Pathway of L-Valine in C. glutamicum |
|
|
224 | (1) |
|
16.4 Regulation of L-Valine Biosynthesis in C. glutamicum |
|
|
225 | (1) |
|
16.4.1 Transcriptional repression |
|
|
226 | (1) |
|
16.4.2 Feedback inhibition |
|
|
226 | (1) |
|
16.4.3 Regulation of transport |
|
|
226 | (1) |
|
16.5 Metabolic Engineering of L-Valine Production in C. glutamicum |
|
|
226 | (4) |
|
16.5.1 Accumulating the key precursors in the biosynthetic pathway of L-valine |
|
|
227 | (1) |
|
16.5.2 Strengthening the biosynthetic pathway of L-valine by overexpressing the key genes |
|
|
227 | (2) |
|
16.5.3 Optimizing L-valine accumulation by chromosomal mutagenesis |
|
|
229 | (1) |
|
16.5.4 Balancing the cofactors to improve L-valine production |
|
|
229 | (1) |
|
|
230 | (4) |
|
|
230 | (1) |
|
|
231 | (3) |
|
17 Flavour Formation From Leucine by Lactic Acid Bacteria (LAB) |
|
|
234 | (10) |
|
|
|
|
|
234 | (1) |
|
|
234 | (2) |
|
17.3 Leucine Catabolic Pathways Among LAB |
|
|
236 | (1) |
|
17.4 Leucine Catabolic Activities and Their Effects on the Sensory Characteristics of Foods |
|
|
237 | (4) |
|
|
241 | (3) |
|
|
241 | (3) |
|
PART VI AROMATIC AMINO ACIDS AND HISTIDINE |
|
|
|
18 Microbial Degradation of Phenolic Amino Acids |
|
|
244 | (12) |
|
|
|
|
244 | (1) |
|
|
244 | (1) |
|
18.3 Phenylalanine Metabolism |
|
|
245 | (1) |
|
|
245 | (1) |
|
18.5 Benzoyl-CoA Reduction Pathway |
|
|
246 | (3) |
|
18.6 Glutaryl-CoA Pathway |
|
|
249 | (1) |
|
18.7 Homology with Mesophilic Bacterial Proteins |
|
|
249 | (2) |
|
18.8 Industrial Applications |
|
|
251 | (1) |
|
|
251 | (5) |
|
|
252 | (4) |
|
19 The Biosynthesis of Tryptophan |
|
|
256 | (11) |
|
|
|
256 | (1) |
|
|
256 | (1) |
|
19.3 Overview of Tryptophan Biosynthesis |
|
|
256 | (1) |
|
19.4 Anthranilate Synthase |
|
|
257 | (3) |
|
19.5 Anthranilate Phosphoribosyltransferase |
|
|
260 | (1) |
|
19.6 Phosphoribosyl Anthranilate Isomerase |
|
|
260 | (1) |
|
19.7 Indole Glycerol Phosphate Synthase |
|
|
261 | (1) |
|
|
262 | (2) |
|
|
264 | (3) |
|
|
264 | (3) |
|
20 Tryptophan Biosynthesis in Bacteria: Drug Targets and Immunology |
|
|
267 | (10) |
|
|
|
267 | (1) |
|
|
267 | (1) |
|
20.3 The Tryptophan Biosynthetic Pathway |
|
|
267 | (1) |
|
20.4 Tryptophan Depletion is a Response of the Innate Immune System |
|
|
268 | (1) |
|
20.5 Mycobacterium tuberculosis is a Globally Significant Human Pathogen |
|
|
269 | (1) |
|
20.6 The Tryptophan Biosynthetic Pathway in Mycobacterium tuberculosis |
|
|
270 | (1) |
|
20.7 Tryptophan Biosynthesis is Essential for Host Colonization by M. tuberculosis |
|
|
270 | (1) |
|
20.8 The Role of Indoleamine 2,3-Dioxygenase 1 (IDO-1) in M. tuberculosis Infection |
|
|
271 | (1) |
|
20.9 Inhibitors of Tryptophan Biosynthesis in M. tuberculosis |
|
|
271 | (2) |
|
20.10 Conclusions and Future Prospects |
|
|
273 | (4) |
|
|
273 | (4) |
|
21 The Kynurenine Pathway of Tryptophan Metabolism in Microorganisms |
|
|
277 | (14) |
|
|
|
277 | (1) |
|
|
277 | (2) |
|
21.3 Distribution of the Kynurenine Pathway in Microorganisms |
|
|
279 | (1) |
|
21.4 Regulation of the Kynurenine Pathway in Microorganisms |
|
|
280 | (1) |
|
21.5 Tryptophan/Indoleamine Dioxygenase |
|
|
280 | (1) |
|
21.6 Kynurenine Formamidase |
|
|
281 | (1) |
|
21.7 Kynurenine Monooxygenase |
|
|
281 | (2) |
|
|
283 | (1) |
|
21.9 3-Hydroxyanthranilate 3,4-Dioxygenase |
|
|
284 | (1) |
|
21.10 2-Amino-3-carboxymuconate Semialdehyde Decarboxylase |
|
|
284 | (1) |
|
21.11 2-Aminomuconate Semialdehyde Dehydrogenase and 2-Aminomuconate Deaminase |
|
|
284 | (2) |
|
21.12 Roles of the Kynurenine Pathway in Microorganisms |
|
|
286 | (2) |
|
|
288 | (3) |
|
|
288 | (3) |
|
22 Histidine Degradation in Bacteria |
|
|
291 | (13) |
|
|
|
|
291 | (1) |
|
22.2 The Histidine Utilization (Hut) Pathway |
|
|
291 | (5) |
|
|
291 | (2) |
|
|
293 | (1) |
|
22.2.3 Imidazolone propionate hydrolase (IPase) |
|
|
293 | (1) |
|
22.2.4 Formiminoglutamate hydrolase (FIGase) |
|
|
293 | (1) |
|
22.2.5 Formiminoglutamate (FIG) deiminase |
|
|
294 | (1) |
|
22.2.6 Formylglutamate hydrolase (FGase) |
|
|
294 | (1) |
|
22.2.7 Histidine and urocanate permeases |
|
|
294 | (1) |
|
22.2.7.1 Urocanate permease in enteric bacteria |
|
|
294 | (1) |
|
22.2.7.2 Histidine and urocanate permeases in pseudomonads |
|
|
294 | (2) |
|
22.2.7.3 The Hut-specific permease of Bacillus subtilis |
|
|
296 | (1) |
|
22.3 Hut Operon Structure and Conservation |
|
|
296 | (2) |
|
22.3.1 The hut operons of enteric bacteria |
|
|
296 | (1) |
|
22.3.2 The hut operons of pseudomonads |
|
|
296 | (1) |
|
22.3.2.1 The hut operons of Pseudomonas putida |
|
|
297 | (1) |
|
22.3.2.2 The kid operons of P. fluorescens |
|
|
297 | (1) |
|
22.3.2.3 The hut operons of P. aeruginosa |
|
|
297 | (1) |
|
22.3.3 The hut operon of Bacillus subtilis |
|
|
297 | (1) |
|
22.4 Regulation of Hut Expression |
|
|
298 | (1) |
|
22.5 Theme and Variation Within the Hut Paradigm |
|
|
298 | (2) |
|
22.5.1 The hut system of Streptomyces spp. |
|
|
298 | (1) |
|
22.5.2 The hut system of Ralstonia eutropha |
|
|
299 | (1) |
|
22.5.3 The hut system of Caulobacter crescentus |
|
|
299 | (1) |
|
22.6 Unanswered Questions |
|
|
300 | (4) |
|
|
300 | (4) |
|
23 The Histidine Phosphatase Superfamily in Pathogenic Bacteria |
|
|
304 | (11) |
|
|
|
|
304 | (1) |
|
|
304 | (1) |
|
23.3 The Histidine Phosphatase Superfamily |
|
|
305 | (4) |
|
23.3.1 Definition and general properties |
|
|
305 | (1) |
|
|
305 | (2) |
|
23.3.3 Structure and mechanism |
|
|
307 | (2) |
|
23.4 Functions of the Histidine Phosphatase Superfamily in Bacteria |
|
|
309 | (2) |
|
23.4.1 Biosynthetic pathways |
|
|
309 | (1) |
|
23.4.2 Scavenging functions |
|
|
310 | (1) |
|
|
310 | (1) |
|
|
310 | (1) |
|
23.5 Role of Histidine Acid Phosphatase Superfamily Proteins in the Pathogenicity of Mycobacterium tuberculosis |
|
|
311 | (1) |
|
|
312 | (3) |
|
|
312 | (3) |
|
|
|
24 Functions and Metabolism of D-Amino Acids in Microorganisms |
|
|
315 | (17) |
|
|
|
|
|
|
315 | (1) |
|
|
315 | (1) |
|
24.3 Functions of D-Amino Acids |
|
|
316 | (3) |
|
24.3.1 Functions of D-amino acids in prokaryotic microorganisms |
|
|
316 | (2) |
|
24.3.2 Functions of D-amino acids in eukaryotic microorganisms |
|
|
318 | (1) |
|
24.4 D-Amino Acid Synthesis |
|
|
319 | (4) |
|
24.4.1 PLP-dependent amino acid racemase |
|
|
319 | (1) |
|
24.4.1.1 Alanine racemase |
|
|
319 | (1) |
|
|
319 | (1) |
|
24.4.1.3 Arginine/lysine racemase |
|
|
320 | (1) |
|
24.4.1.4 Broad substrate specificity amino acid racemase |
|
|
320 | (1) |
|
24.4.2 PLP-Independent amino acid racemase |
|
|
321 | (1) |
|
24.4.2.1 Aspartate racemase |
|
|
321 | (1) |
|
24.4.2.2 Glutamate racemase |
|
|
321 | (1) |
|
24.4.2.3 Proline racemase |
|
|
322 | (1) |
|
24.4.2.4 Phenylalanine racemase (gramicidin S synthetase A) |
|
|
322 | (1) |
|
24.4.3 D-Amino acid aminotransferase |
|
|
322 | (1) |
|
24.4.4 Enzyme side reactions |
|
|
323 | (1) |
|
24.5 D-Amino Acid Degradation |
|
|
323 | (3) |
|
24.5.1 D-Amino acid oxidase |
|
|
323 | (1) |
|
24.5.2 D-Aspartate oxidase |
|
|
324 | (1) |
|
24.5.3 D-Amino acid dehydrogenase |
|
|
324 | (1) |
|
24.5.4 D-Serine/threonine dehydratase |
|
|
325 | (1) |
|
24.5.5 D-Proline reductase |
|
|
326 | (1) |
|
24.5.6 D-Threonine aldolase |
|
|
326 | (1) |
|
|
326 | (6) |
|
|
326 | (6) |
|
25 Pathways of Utilization of D-Amino Acids in Higher Organisms |
|
|
332 | (20) |
|
|
|
332 | (1) |
|
|
333 | (1) |
|
25.3 Occurrence of D-Amino Acids in Higher Organisms |
|
|
334 | (1) |
|
|
334 | (1) |
|
25.4 Endogenous Synthesis and Degradation of D-Amino Acids in Higher Organisms |
|
|
334 | (4) |
|
25.4.1 Amino acid racemases |
|
|
336 | (1) |
|
25.4.2 D-Amino acid oxidases |
|
|
337 | (1) |
|
|
337 | (1) |
|
25.5 Food Composition and Safety |
|
|
338 | (2) |
|
25.6 Feeding and Nutrition |
|
|
340 | (4) |
|
25.6.1 Case study: D-amino acid kinetics in the ruminant animal |
|
|
342 | (2) |
|
|
344 | (1) |
|
25.8 Clinical Applications: Emerging Potential |
|
|
345 | (1) |
|
|
345 | (7) |
|
|
346 | (6) |
|
|
|
26 Rhizobial Amino Acid Metabolism: Polyamine Biosynthesis and Functions |
|
|
352 | (19) |
|
|
|
352 | (1) |
|
26.2 Introduction and Scope |
|
|
352 | (1) |
|
26.3 Polyamine Chemistry, Detection and Analysis |
|
|
353 | (1) |
|
26.4 Physiological Functions of Polyamines in Non-rhizobia |
|
|
353 | (1) |
|
26.5 Synthesis and Degradation of Polyamine Precursors in Rhizobia |
|
|
354 | (3) |
|
|
355 | (1) |
|
26.5.2 Ornithine and arginine |
|
|
355 | (2) |
|
26.6 Synthesis and Transport of Polyamines in Rhizobia |
|
|
357 | (4) |
|
26.6.1 Polyamines produced by rhizobia under free-living and symbiotic conditions |
|
|
357 | (1) |
|
26.6.2 Polyamine biosynthesis in rhizobia |
|
|
358 | (1) |
|
26.6.3 Polyamine transport in rhizobia |
|
|
359 | (1) |
|
26.6.4 Polyamine degradation in rhizobia |
|
|
359 | (2) |
|
26.7 Functions of Polyamines in Free-Living Rhizobia |
|
|
361 | (4) |
|
26.7.1 Requirement of polyamines for growth |
|
|
361 | (1) |
|
26.7.2 Polyamines and motility |
|
|
361 | (1) |
|
26.7.3 Polyamines and biofilm formation |
|
|
361 | (2) |
|
26.7.4 Polyamines in abiotic stress resistance |
|
|
363 | (2) |
|
26.8 Functions of Polyamines in Symbiotically-Associated Rhizobia |
|
|
365 | (1) |
|
26.8.1 Influence of polyamines on nodulation and nitrogen fixation |
|
|
365 | (1) |
|
26.8.2 Influence of polyamines on symbiosis under stress conditions |
|
|
365 | (1) |
|
|
365 | (6) |
|
|
366 | (1) |
|
|
366 | (5) |
|
27 Working Together: Amino Acid Biosynthesis in Endosymbiont-harbouring Trypanosomatidae |
|
|
371 | (13) |
|
|
|
371 | (1) |
|
|
371 | (1) |
|
27.3 In silico Metabolic Reconstruction |
|
|
372 | (1) |
|
27.4 Essential Amino Acid Biosynthesis |
|
|
373 | (5) |
|
27.4.1 Arginine and ornithine |
|
|
373 | (2) |
|
27.4.2 Cysteine and methionine |
|
|
375 | (1) |
|
|
376 | (1) |
|
27.4.4 Isoleucine, leucine and valine |
|
|
376 | (1) |
|
|
377 | (1) |
|
27.4.6 Phenylalanine, tyrosine and tryptophan |
|
|
377 | (1) |
|
|
377 | (1) |
|
27.5 Non-essential Amino Acid Biosynthesis |
|
|
378 | (2) |
|
27.5.1 Glycine and serine |
|
|
378 | (1) |
|
27.5.2 Alanine, aspartate and asparagine |
|
|
378 | (1) |
|
|
379 | (1) |
|
27.5.4 Glutamine and glutamate |
|
|
379 | (1) |
|
|
380 | (4) |
|
|
381 | (3) |
|
28 Amino Acid Metabolism in Helminths |
|
|
384 | (14) |
|
|
|
|
384 | (1) |
|
|
384 | (1) |
|
|
384 | (1) |
|
|
385 | (1) |
|
28.4.1 Glutamate dehydrogenase |
|
|
386 | (1) |
|
28.4.2 Glutamine synthetase (GS)-glutamate synthase (GOGAT) |
|
|
386 | (1) |
|
|
386 | (1) |
|
28.4.4 GABA (γ-aminobutyrate) shunt |
|
|
386 | (1) |
|
|
386 | (1) |
|
|
387 | (1) |
|
|
387 | (1) |
|
28.6.2 Ornithine urea cycle |
|
|
387 | (1) |
|
28.6.3 Nitric oxide synthase (NOS) |
|
|
387 | (1) |
|
|
387 | (1) |
|
|
387 | (1) |
|
|
388 | (1) |
|
28.7 Glycine, Sarcosine, Serine and Threonine |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
389 | (1) |
|
28.8 Methionine and Cysteine |
|
|
389 | (1) |
|
|
389 | (1) |
|
28.9 Leucine, Isoleucine and Valine |
|
|
389 | (1) |
|
28.10 Tyrosine, Phenylalanine and Tryptophan |
|
|
389 | (1) |
|
|
390 | (1) |
|
28.10.2 Chorismate mutase (CM) |
|
|
390 | (1) |
|
|
390 | (1) |
|
28.12 Aspartate and Asparagine |
|
|
390 | (1) |
|
|
391 | (1) |
|
|
391 | (7) |
|
|
391 | (7) |
|
29 Microbial Degradation of Amino Acids in Anoxic Environments |
|
|
398 | (20) |
|
|
|
|
398 | (1) |
|
|
398 | (2) |
|
29.3 Unusual Reactions in Amino Acid Fermentation |
|
|
400 | (1) |
|
29.4 The 2-Hydroxyacid Pathway |
|
|
400 | (3) |
|
29.4.1 Pathway and mechanism of dehydration |
|
|
400 | (1) |
|
29.4.2 Activation of 2-hydroxyacyl-CoA dehydratase (2-HADH) |
|
|
401 | (2) |
|
29.4.3 Bioenergetics of the 2-hydroxyacid pathways |
|
|
403 | (1) |
|
29.4.4 Reaction constants of 2-HADH and physiological implications |
|
|
403 | (1) |
|
29.5 The 4-Hydroxybutyrate and 5-Hydroxyvalerate Pathways: Flavin-mediated Elimination of the Terminal Hydroxy Groups |
|
|
403 | (1) |
|
29.5.1 The 4-hydroxybutyrate pathway |
|
|
403 | (1) |
|
29.5.2 The 5-hydroxyvalerate pathway |
|
|
404 | (1) |
|
29.6 Pathways via Carbon Skeleton Rearrangements |
|
|
404 | (3) |
|
29.6.1 Lysine fermentation via 3,5-diaminohexanoate |
|
|
404 | (2) |
|
29.6.2 The 3-methylaspartate (mesaconate) pathway |
|
|
406 | (1) |
|
29.6.2.1 Glutamate mutase |
|
|
407 | (1) |
|
29.7 Energy Conservation in Anaerobes and Electron Bifurcation |
|
|
407 | (3) |
|
29.7.1 Anaerobic energy metabolism |
|
|
407 | (1) |
|
29.7.2 Ferredoxins and anaerobic metabolism |
|
|
408 | (1) |
|
29.7.3 Flavin-based electron bifurcation (FBEB) |
|
|
408 | (1) |
|
29.7.4 A Membrane-Associated Rhodobacter Nitrogen Fixation Protein (Rnf)-Complex For Ferredoxin Reoxidation and Energy Conservation |
|
|
409 | (1) |
|
29.8 Biotechnological Applications of Amino Acid Fermentation |
|
|
410 | (1) |
|
29.9 Medical and Environmental Aspects of Amino Acid Fermentation |
|
|
411 | (1) |
|
|
411 | (1) |
|
29.9.2 Environmental aspects |
|
|
411 | (1) |
|
|
412 | (6) |
|
|
412 | (1) |
|
|
412 | (6) |
|
30 Utilization of N-Methylated Amino Acids by Bacteria |
|
|
418 | (15) |
|
|
|
418 | (1) |
|
|
418 | (1) |
|
30.3 Glycine Betaine and Its Metabolites |
|
|
419 | (3) |
|
|
419 | (1) |
|
30.3.2 Roles in pathogenesis, symbiosis and osmoprotection |
|
|
420 | (1) |
|
|
421 | (1) |
|
|
421 | (1) |
|
30.4 N-Methylated Prolines |
|
|
422 | (2) |
|
|
422 | (1) |
|
30.4.2 Roles in symbiosis and osmoprotection |
|
|
423 | (1) |
|
|
423 | (1) |
|
|
423 | (1) |
|
30.5 Histidine Betaine and Its Metabolites |
|
|
424 | (1) |
|
|
424 | (1) |
|
30.5.2 Role in bacterial biology |
|
|
425 | (1) |
|
|
425 | (1) |
|
|
425 | (1) |
|
30.6 N-Methylated Tryptophan |
|
|
425 | (1) |
|
30.7 N-Methylated Tyrosine |
|
|
426 | (1) |
|
|
426 | (7) |
|
|
426 | (7) |
|
31 Biofilm Formation: Amino Acid Biomarkers in Candida Albicans |
|
|
433 | (11) |
|
|
|
|
433 | (1) |
|
|
433 | (2) |
|
|
435 | (2) |
|
31.4 The Initiation Phase |
|
|
437 | (1) |
|
31.5 The Maturation and Dispersal Phase |
|
|
438 | (2) |
|
31.6 Amino Acids and the Tricarboxylic Acid (TCA) Cycle |
|
|
440 | (1) |
|
31.7 Drug Therapies and C. albicans Biofilms |
|
|
440 | (1) |
|
|
441 | (3) |
|
|
442 | (2) |
|
|
|
32 Recent Advances Underpinning Innovative Strategies for the Future |
|
|
444 | (12) |
|
|
|
444 | (2) |
|
|
446 | (2) |
|
32.3 Unlocking Practical Value |
|
|
448 | (2) |
|
|
450 | (1) |
|
|
450 | (1) |
|
|
450 | (1) |
|
|
451 | (1) |
|
32.8 Branched-chain Amino Acids |
|
|
451 | (3) |
|
32.9 Aromatic Amino Acids |
|
|
454 | (1) |
|
32.9.1 Phenylalanine and tyrosine |
|
|
454 | (1) |
|
|
455 | (1) |
|
32.10 Secondary Metabolism |
|
|
455 | (1) |
|
|
456 | (12) |
|
32.12 Host-microbe Interactions |
|
|
457 | (3) |
|
|
457 | (1) |
|
32.12.1.1 Microbial metabolism of non-protein amino acids: contrasting observations |
|
|
457 | (1) |
|
32.12.1.2 The host-pathogen axis |
|
|
458 | (2) |
|
32.13 Antimicrobial Chemotherapy: Potential Targets in Pathways of Amino Acid Metabolism |
|
|
460 | (3) |
|
32.13.1 Drug/fungicide resistance |
|
|
463 | (1) |
|
32.14 Summary of Outcomes |
|
|
463 | (4) |
|
|
464 | (1) |
|
|
464 | (1) |
|
32.14.3 Enzyme and biochemical characterization of microorganisms |
|
|
464 | (1) |
|
32.14.4 Metabolic pathways |
|
|
465 | (1) |
|
32.14.5 Antagonisms and synergism |
|
|
465 | (1) |
|
32.14.6 Amino acid metabolism and disease |
|
|
466 | (1) |
|
32.14.7 Pathogenicity and virulence |
|
|
466 | (1) |
|
|
467 | (1) |
|
|
467 | (1) |
|
|
467 | (1) |
|
|
468 | (1) |
References |
|
468 | (11) |
Index |
|
479 | |